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Abstract
Background: Current guidelines and targets for soil-transmitted helminth (STH) control focus on school-based
deworming for school-age children, given the high risk of associated morbidity in this age group. However,
expanding deworming to all age groups may achieve improved STH control among both the community in
general and school-age children, by reducing their risk of reinfection. This trial aims to compare school-based
targeted deworming with community-wide mass deworming in terms of impact on STH infections among school-
age children.
Methods: The CoDe-STH (Community Deworming against STH) trial is a cluster-randomised controlled trial (RCT) in
64 primary schools in Dak Lak province, Vietnam. The control arm will receive one round of school-based targeted
deworming with albendazole, while in the intervention arm, community-wide mass deworming with albendazole
will be implemented alongside school-based deworming. Prevalence of STH infections will be measured in school-
age children at baseline and 12 months following deworming. The primary outcome is hookworm prevalence in
school-age children at 12 months, by quantitative PCR. Analysis will be intention-to-treat, with outcomes compared
between study arms using generalised linear and non-linear mixed models. Additionally, cost-effectiveness of mass
and targeted deworming will be calculated and compared, and focus group discussions and interviews will be
used to assess acceptability and feasibility of deworming approaches. Individual based stochastic models will be
used to predict the impact of mass and targeted deworming strategies beyond the RCT timeframe to assess the
likelihood of parasite population ‘bounce-back’ if deworming is ceased due to low STH prevalence.
Discussion: The first large-scale trial comparing mass and targeted deworming for STH control in South East Asia
will provide key information for policy makers regarding the optimal design of STH control programs.
Trial registration: ACTRN12619000309189.
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Background
Soil-transmitted helminths (STH), comprising round-
worm (Ascaris lumbricoides), hookworms (Necator
americanus, Anyclostoma duodenale and Ancylostoma
ceylanicum), and whipworm (Trichuris trichiura) are the
most prevalent of the neglected tropical diseases
(NTDs), a group of illnesses that primarily affect people
in low income settings, contributing to an ongoing pov-
erty cycle [1]. Morbidity associated with STH infections
includes impaired physical and cognitive development
and iron-deficiency anaemia, with children and women
of reproductive age at particular risk [2–4].
Over the past decade a global commitment to improv-
ing NTD control has seen the scale-up of STH control
programs in endemic areas [5], predominantly based on
large-scale preventive chemotherapy, in which deworm-
ing drugs—mebendazole or albendazole—are delivered
at regular intervals [5]. Such programs can be either
“targeted” to specific at-risk groups (e.g., by age group or
occupation), or “mass”, with treatment delivered to the
entire population [6].
The World Health Organization (WHO) 2020 target
for STH control is regular deworming of 75% of pre-
school- and school-age children (aged 2–4 years and 5–
12 years, respectively) in endemic areas [7]. In 2017, 596
million school-age children and 227 million preschool-
age children required preventive chemotherapy for STH
[8]. The success of deworming programs has been bol-
stered by the donation of 600 million annual doses of
mebendazole and albendazole by pharmaceutical com-
panies (Johnson & Johnson and Glaxo Smith Kline) to
cover school-age children [9], with recent figures sug-
gesting that overall progress is on track to meet the
2020 targets [8]. School-based targeted deworming pro-
grams represent the mainstay of STH control efforts,
utilising existing school-based infrastructure to reach a
large proportion of school-age children, with teachers
acting as drug distributors [6, 10, 11].
WHO guidelines published in 2017 recommend
regular deworming of not only preschool- and school-
age children, but also children aged 12–23 months,
adolescent girls (aged 10–19 years) and women of
childbearing age (15–49 years) in endemic areas [12],
and there have been calls for expansion to treat all
age groups [13]. Community-wide treatment is suc-
cessfully used for other NTDs, including lymphatic
filariasis, trachoma, and onchocerciasis [14–16]. Math-
ematical modelling has demonstrated that deworming
of school-age children is unlikely to have a significant
impact on community-wide transmission, especially for
hookworm, because large reservoirs of infection exist in
adults [17–19]. Furthermore, a systematic review and
meta-analysis of studies conducting either mass or tar-
geted deworming showed that treating entire communities
significantly enhances STH prevalence reduction among
school-age children [20].
Our recent pilot study in Timor-Leste compared
school- and community-based approaches to STH con-
trol, providing proof of principle for the hypothesis that
a community-wide approach leads to greater STH preva-
lence reduction among school-age children [21]. The
recent TUMIKIA study in Kenya reported lower hook-
worm prevalence across all age groups following annual
community-wide deworming, compared to school-based
deworming [22]. The ongoing Deworm3 study in Benin,
Malawi and India is also comparing community-wide
and school-based deworming [23]. No community trials
comparing mass and targeted deworming have been
conducted in South East Asia.
The CoDe-STH trial aims to test the hypothesis that
community-wide STH control programs will lead to
fewer reinfections among school-age children in a South
East Asian setting. Specific objectives are:
1. To compare the impact of targeted deworming and
mass deworming on the prevalence and intensity of
STH infections among school-age children;
2. To evaluate and compare the cost-effectiveness of
targeted deworming and mass deworming;
3. To examine the acceptability and feasibility of
school-based and community-based deworming;
4. To predict the long-term impact of targeted
deworming and mass deworming on STH
transmission using individual based stochastic
models of parasite transmission.
Methods/design
This study protocol has been prepared according to the
SPIRIT (Standard Protocol Items: Recommendations for
Intervention Trials) recommendations [24].
Overview of study design
The CoDe-STH trial design is depicted in Fig. 1. The
trial is a two-arm cluster randomised controlled trial
(RCT), with each cluster being a primary school located
in Dak Lak Province, Vietnam. It has been designed to
evaluate the impact of community-wide mass deworm-
ing on STH infections among school-age children, com-
pared to primary school-based targeted deworming. In
the control arm (32 clusters), one round of school-based
targeted deworming with albendazole will be conducted
at primary schools. In the intervention arm (32 clusters),
community-based mass deworming with albendazole
will be implemented alongside school-based deworming.
STH infections will be detected using quantitative poly-
merase chain reaction (qPCR) on stool samples collected
from school-age children during surveys at baseline and
12months following deworming. A 12-month follow-up
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period was selected based on the Vietnamese national
deworming schedule, as well as evidence that one round
of deworming will lead to significant reduction in STH
prevalence at 12 months [20].
This trial has received ethical approval from the Hu-
man Research Ethics Committees at the University of
New South Wales (HC190136) and Tay Nguyen Univer-
sity (1804-QĐ-ĐHTN-TCCB), and is registered with the
Australian New Zealand Clinical Trials Registry (regis-
tration number ACTRN12619000309189).
Study setting
Dak Lak province is located in the Central Highlands of
Vietnam (see Fig. 2), and has a population of approxi-
mately 1.9 million [25]. The province is comprised of
one provincial city (Buôn Ma Thu t), one district-level
town (Buôn Hồ), and 13 districts. Together, the provin-
cial city, district-level town, and districts are comprised
of 182 communes, wards and towns, with each further
subdivided into hamlets, generally comprising between
100 and 1000 households. The trial will take place in all
13 districts.
Dak Lak province has implemented large-scale
deworming of primary school-age children with meben-
dazole or albendazole since 2007 as part of the national
STH control program. Deworming has taken place twice
annually since 2014, apart from 2018 because of difficul-
ties in procuring mebendazole. Due to decreasing STH
prevalence, from 2019 onwards, deworming will be con-
ducted once annually (D. Nguyen, personal communica-
tion). We conducted a preliminary survey in 13 primary
schools across Dak Lak province in December 2018 in
preparation for the CoDe-STH trial. This survey re-
vealed an overall hookworm prevalence, using qPCR, of
20.6%, with school-level prevalences ranging from 3.2 to
55.2% (unpublished data). Prevalence of A. lumbricoides
and T. trichiura were much lower at 2.5 and 1.1%, re-
spectively. These findings were very similar to those re-
ported in a survey of four primary schools conducted in
2015 [26].
The research field team will consist of a local pro-
ject manager and six field supervisors from Tay
Nguyen University, four local staff recruited from the
Department of Health and Department of Education
in each district, and local hamlet health workers (one
per participating hamlet).
Intervention
Albendazole will be used as the deworming drug for the
study intervention, given that it has higher efficacy than
mebendazole against hookworm [27] and is more widely
used in STH control programs [5]. One round of deworm-
ing will be conducted in both study arms in November
2019. In the control arm, we will conduct school-based
deworming only. All children attending each study school
(typically aged 6-11 years) will receive the recommended
Fig. 1 Flow diagram of the trial
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400mg dose of albendazole [12], using the same proce-
dures as the regular Ministry of Health deworming
program.
In the intervention arm, we will conduct both school-
based and community-wide deworming. All schoolchil-
dren will receive albendazole as described above. In
addition, community-based deworming will be imple-
mented in hamlets where children enrolled in the pri-
mary school live. For each school, we will select enough
hamlets for community deworming to ensure that at
least 70% of children enrolled in the school are resident
in a treated hamlet. While 100% coverage of hamlets in
catchment communities would have been ideal, the
lower proportion was selected due to financial and logis-
tical constraints. Preliminary data from the Department
of Education and Training indicate that 70% coverage
will generally require treating between 1 and 4 hamlets
per school. In each selected hamlet, house-by-house
visits will be conducted and albendazole 400 mg offered
to every household member, excluding children who
already received albendazole at school. As per WHO
guidelines, children under the age of 1 year will not re-
ceive albendazole, and children aged 12–23 months will
receive 200 mg [12]. Pregnant women in the first trimes-
ter (defined as all those who report being pregnant but
have not felt the baby move, and those who report miss-
ing their last menstrual period) will also be excluded
from treatment following WHO guidelines.
In both arms, albendazole will be distributed by ham-
let health workers and district-level Department of
Fig. 2 Map of Vietnam showing Dak Lak province and its second-tier administrative units (districts, town and city)
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Health staff. All doses will be taken under direct obser-
vation. Due to the nature of the intervention, neither
study participants nor research team members can be
blinded.
Albendazole is known to be extremely safe when deliv-
ered in single doses [28], with hundreds of millions of
doses delivered annually in deworming programs for
STH and lymphatic filariasis [8, 15]. Participants will be
advised to attend the local commune medical station if
they are unwell following drug distribution. Medical sta-
tions will be advised of the deworming activities. Passive
monitoring of adverse events will be undertaken as de-
scribed further below.
Study outcomes
The primary outcome is the prevalence of hookworm in-
fection (unspeciated) detected using qPCR, 12 months
after deworming. Secondary outcomes are prevalence of
N. americanus, A. duodenale, A. ceylanicum (i.e. species-
specific hookworm infections), Ascaris spp., and T. tri-
chiura by qPCR; mean intensity of hookworm infection,
calculated as the average number of eggs per gram of
faeces; treatment coverage with albendazole (i.e., the
proportion of eligible schoolchildren and community
members who receive albendazole); and adverse events
following albendazole distribution.
Selection and randomisation of clusters
Schools are eligible to participate in the study if they
meet the following criteria:
a) Defined by the Department of Education and
Training as a primary school (grades 1–5)
b) Have between 200 and 450 students enrolled (due
to sample size requirements and operational
constraints)
c) Located in a rural, remote, or very remote area, as
defined by Department of Education and Training.
In June 2019, a list of schools meeting these criteria
was generated with assistance from the Department of
Education and Training. Out of 423 primary schools in
Dak Lak province, 129 met eligibility criteria, and 64
were randomly selected from this list, stratified by dis-
trict to ensure good geographic coverage. To ensure that
no study schools shared hamlets in their catchment
areas, no more than one school was selected from a
given commune. The remaining 65 eligible schools were
retained as potential replacement schools.
Selected study schools and replacement schools were
randomised 1:1 to the control and intervention arms,
stratified by district. Randomisation was performed by
an independent, blinded statistician, using a compu-
terised random number generator.
Participants
Participation in data collection involves providing a stool
sample and completing a questionnaire. For each school,
participants in data collection will be school-age children
in grades 1–4 (typically aged 6–10), residing in hamlets
that collectively include as residents at least 70% of chil-
dren enrolled in the primary school. The participants
will be followed across both data collection time points;
therefore, children in grade 5 will not be recruited for
data collection, because they will no longer be in pri-
mary school at the 12-month follow-up. All children in
grades 1–4 who reside in the selected hamlets will be eli-
gible to participate in the study, provided their parents
provide informed consent (see below). In both arms, in
accordance with national and WHO deworming policies,
all children attending school will receive albendazole, re-
gardless of whether they participate in data collection.
Engagement and recruitment
Key stakeholders in Dak Lak province, including the
Center for Parasitic Disease Control and Prevention
and the Department of Education and Training, have
been involved in this study from an early stage, and
have provided input into the study design, timing,
and procedures.
In the several months prior to baseline study visits, ini-
tial engagement visits will be conducted in all 13 dis-
tricts of Dak Lak province. During these visits, members
of the research team will hold meetings with the district
level Department of Health and Department of Educa-
tion and Training, to describe the study aims, interven-
tions, and data collection procedures. Each selected
study school will then be visited and the study described
to the school principals and teachers. Verbal consent will
be sought from the principal to conduct data collection
and deworming in the school. If consent is not obtained
(a circumstance considered unlikely by local collabora-
tors), a replacement school will be randomly selected
from the pre-generated, pre-randomised replacement list
of schools. Once a principal has agreed, a meeting will
be held with commune and hamlet leaders from partici-
pating hamlets, to describe the study, seek their support
in encouraging parent and community participation, and
identify a health worker per hamlet to assist with com-
munity mobilisation. For hamlets in the intervention
arm, verbal consent will be sought from the stakeholders
above to conduct community deworming.
At study baseline, each school principal will organise a
meeting at the school between the research team and par-
ents/guardians of children who live in the selected ham-
lets. Hamlet health workers will encourage parent
attendance. The trial purpose, procedures, data collection,
and interventions will be explained to parents, and an op-
portunity provided for questions. Written information
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sheets will be distributed (see Additional file 1 for the Eng-
lish version) and written informed consent will be sought
from parents/guardians by members of the research team
for children to participate in data collection. For parents
who do not attend the meeting, written information state-
ments and consent forms will be sent home. Consent will
not be sought for children to receive albendazole at
school, because school-based deworming is usual practice
in Vietnam, and the trial will follow similar procedures to
those used by the Ministry of Health deworming program.
In intervention clusters, hamlet-level meetings will be
arranged by the hamlet leader, at which the research
team will explain the study to members of communities
that will be offered the deworming intervention. Written
informed consent will subsequently be sought by mem-
bers of the research team during house-to-house visits
for albendazole distribution. Similar procedures will be
used for participant engagement and recruitment at
follow-up.
Data collection
Once written information consent has been obtained
from parents/guardians, the study will be explained to
the children from hamlets selected for participation in
data collection. A questionnaire (see Additional file 2 for
the English version) will be administered at study
baseline to each child and his/her parent or guardian.
This will be done at the primary school immediately fol-
lowing the parent meeting, via interview with a trained
member of the research team. The interview will be con-
ducted in Vietnamese and will take approximately 10
min to complete. Questions will relate to participants’
defecation and hygiene practices (asked to children), as
well as household water sources, home environment and
socioeconomic status (asked to parents).
Parasitological surveys will be done at study baseline
and 12 months after deworming. On the first day of data
collection, participating children will be instructed on
how to collect a stool sample and provided with a collec-
tion kit. They will be asked to collect an early morning
stool sample the following morning and bring it with
them to school. The research team will be present at the
school for 3 days in total, so will be present to receive
stool samples for 2 days. Research team members will
process stool samples immediately in the field, preserv-
ing a 3-g aliquot in 5% (w/v) potassium dichromate. Ali-
quots will be kept chilled until refrigerated.
Preserved stool samples will be sent to the University
of Melbourne, Australia, for analysis using quantitative
PCR [29, 30]. Following washing and beating steps,
DNA extraction will be performed using the Maxwell®
RSC PureFood GMO and Authentication Kit on a Max-
well® RSC 48 Instrument (Promega Corporation). This
will be followed by two real-time multiplex PCR assays:
one to detect and quantify N. americanus, A. duodenale,
and A. ceylanicum, and the other to detect and quantify
Ascaris spp. and T. trichiura, using Equine Herpes Virus
4 and human DNA as qPCR internal and extraction con-
trols, respectively. Infection intensity will be determined
using standardised curves of faeces seeded with eggs of
each species, to convert cycle threshold (Ct) values ob-
tained from PCR into eggs per gram of faeces. Labora-
tory staff conducting the STH diagnosis will be blinded
to participants’ allocation.
Treatment coverage will be documented by recording
the number of albendazole doses delivered and taken by
students at each school, as well as the total number of
students enrolled in each school. In the intervention
arm, the number of albendazole doses delivered and
taken by each household will be documented, and the
population of each hamlet obtained from the hamlet
leader.
Adverse events will be recorded using passive monitor-
ing. At the time of deworming, teachers and hamlet
health workers will be trained by the research team to
recognise and document adverse events related to
deworming, including abdominal pain, diarrhoea, nau-
sea, headache and dizziness [28]. Members of the re-
search team will return to study schools 1 week
following deworming, to collate information about po-
tential adverse events from teachers and hamlet health
workers, as well as from commune medical stations.
Sample size calculation
Sample size calculations were based on the primary out-
come, prevalence of hookworm infection. To estimate
the number of clusters required, we used our previously
published generalised linear model to predict the impact
of mass and targeted deworming on prevalence reduc-
tion in school-age children [20]. Assuming a baseline
hookworm prevalence of 20%, the model predicts a rela-
tive prevalence reduction of 79% after mass deworming
and 45% after targeted deworming, measured 12months
after one round of deworming. Assuming an average
cluster size of 120 children in the target age group and
an intra-cluster correlation coefficient of 0.12 [31], with
a power of 80% and α = 0.05, the sample size required to
detect this reduction or greater as significant is 64 pri-
mary schools, randomised 1:1 between the two study
arms. Given the predicted low starting prevalences of A.
lumbricoides and T. trichiura, the study is not powered
to detect a difference between study arms for these STH.
To achieve the required sample size of 120 partici-
pants per cluster, we will initially aim to recruit at least
180 participants per cluster. This will allow for a loss to
follow-up of up to 30%. The estimated total number of
participants in data collection is 7680.
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Data management
Data will be collected using electronic tablets, with RED-
Cap electronic data capture tools [32] hosted at UNSW
Sydney. Data will be collected offline and sent to the se-
cure REDCap server daily using a secure wireless con-
nection. Results of the qPCR analysis will be entered
into a customised database and sent securely to UNSW
Sydney. Regular data management meetings will be held
to examine data quality and completeness, and review
any queries. Trial data will be accessible only by a lim-
ited number of study investigators. De-identified data
will also be provided to the Center for Parasitic Disease
Control & Prevention in Dak Lak province.
Statistical analysis
Intention-to-treat analyses will be conducted to compare
study outcomes between the intervention and control
arms. Unadjusted analyses will involve comparing infec-
tion prevalence and intensity between study arms at
study follow-up, using univariable regression analyses
accounting for clustering by school. For adjusted ana-
lyses, generalised linear and non-linear mixed models
will be used to account for within and between cluster
variability. For infection prevalence, the outcome will be
the infection status of the individual, so Bernoulli logistic
regression will be used. For infection intensity, linear re-
gression models will be used. For all models, age and sex
will be entered as covariates (fixed effects), and school as
a random effect. The intervention will be entered as a
binary fixed effect to estimate differences in prevalence
and intensity, and a relative risk of infection, comparing
the two arms at each follow-up survey. All analyses will
be conducted using a 5% level of significance.
Baseline characteristics will be compared between the
intervention and control arms using descriptive statis-
tics. If there is a need to adjust for differences in the
baseline characteristics of the intervention and control
groups, additional analyses will be conducted incorporat-
ing variables measured in the study questionnaires as co-
variates, allowing an adjusted effect estimate to be
calculated for the intervention.
Assessment of acceptability and feasibility
A mixed-methods study will be undertaken to identify
perceptions, barriers and facilitators to community-wide
deworming in Vietnam, in order to inform policymakers
regarding implementation and scale-up of community-
based deworming. The acceptability of school-based and
community-wide deworming will be examined using a
series of focus group discussions (FGDs) with commu-
nity members, school headmasters, and teachers, con-
ducted following the first round of deworming. The
FGDs will take place in randomly selected schools and
hamlets in both study arms, stratified by district.
Purposive sampling of community members will be
used, to ensure inclusion of community members across
different age groups (including school-age children), so-
cioeconomic positions, and cultural groups, and repre-
sentation of both males and females. Individual semi-
structured interviews will additionally be held with com-
munity leaders, school headmasters, and teachers. FGDs
and interviews will explore perceptions of community-
based deworming for STH control, and perceived bar-
riers and facilitators at individual and community levels.
Feasibility of community-based deworming for STH
control will be explored using individual semi-structured
interviews with key stakeholders, to identify perceptions
and perceived barriers and facilitators at programmatic
and policy levels. Interviews will be held with national,
provincial, and district-level staff of the national NTD
control program, and health staff at district and com-
mune levels.
Written informed consent will be obtained prior to
FGDs and interviews, which will be conducted in
Vietnamese and recorded digitally. Following completion
of the FGDs and interviews, recordings will be tran-
scribed and translated. Coding and analysis will be done
using NVivo software (QSR International, Doncaster,
Australia). Key themes will be identified and analysed
using thematic analysis.
Cost-effectiveness analyses
Two analyses of the incremental cost-effectiveness of the
community-based strategy compared with the school-
based strategy will be undertaken. The first analysis will
use a short time frame (12 months) and will be based on
cost and health outcomes observed in the trial. Costs
will be estimated from the perspective of the Depart-
ments of Health and Education, and will include finan-
cial expenditure and the opportunity cost of using
existing staff and resources. Resource use data will be
collected prospectively through project and accounting
records, and valued using the international drug price
indicator guide, and local market prices and labour
costs. Total implementation costs will be organised into
consumables versus staffing costs to allow us to estimate
the relative contribution of different components to total
program costs. The second analysis will use a 10-year
time frame to look at the longer-term efficiency of a
community-based strategy. Costs for years 2–10 will be
extrapolated from expenditure estimates, excluding one
off start-up costs. Total annual costs for each control
strategy will be reported in Vietnamese Dong (VND)
and adjusted to a common cost year, with standard dis-
count rates applied where necessary. Health outcomes
will be estimated using the WORMSIM mathematical
model to capture the transmission dynamics of hook-
worm infection [19]. The primary outcome will be
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Disability-Adjusted Life Years (DALYs) averted due to
preventing hookworm infections. This will be calculated
using the methods developed for the Global Burden of
Disease study [33]. The relative change in costs and
effectiveness will be used to calculate an incremental
cost-effectiveness ratio for the community-wide and
school-based STH control strategies. Results will be pre-
sented as both the incremental cost per infection
avoided and the incremental cost per DALY averted, to
enable comparison with the efficiency of other large
scale public health programs. We will undertake one-
way and probabilistic sensitivity analyses to understand
the robustness of our conclusions.
Mathematical modelling
Two mathematical models will be used to enhance un-
derstanding of trial findings and predict long-term im-
pact of the two deworming approaches. We will use the
existing individual-based mathematical model WORM-
SIM and an individual-based version of that employed
by the Imperial College team to simulate qPCR results
[19, 34]. Model parameters for the overall transmission
rate and inter-individual variation in exposure will be
calibrated against baseline distribution of infection in-
tensity and prevalence by age. We will then use the
model to predict the impact of interventions in each trial
arm given information on deworming coverage and indi-
vidual treatment compliance, and compare predictions
to trial results. To capture and carry forward stochastic
and parametric uncertainty, model parameters will be
calibrated within a Bayesian framework, using a sequen-
tial Monte Carlo approach [35]. Important discrepancies
between observed data and model predictions will be ex-
plored using alternative plausible model parameterisa-
tions in an iterative fashion. Using the model, we will
further evaluate how sensitive the achievement of disease
control (defined as prevalence of moderate-to-heavy
intensity infection < 1%) is to pre-control transmission
parameters, including rate of transmission and the up-
take of deworming. Finally, we will predict at what over-
all prevalence level by qPCR stopping mass or targeted
deworming will result in transmission being interrupted
with a defined probability [36, 37].
Dissemination
The trial results will be formally presented to the
Vietnamese Ministry of Health and the Dak Lak Prov-
ince Centre for Parasitic Diseases Control and Preven-
tion, and a summary of the results will be provided to
the Department of Health in each district of Dak Lak
province. Results will also be disseminated to key stake-
holders in deworming policy, including the WHO.
The results of the trial will be published in peer-reviewed
journals and presented at international conferences. The
primary outcomes of the trial will be reported following
CONSORT guidelines for cluster RCTs. Results of cost-
effectiveness analyses, feasibility and acceptability of school
and community deworming, and mathematical modelling
will be prepared as separate publications. De-identified data
will be available on request, following completion of the
trial and publication of the trial results.
Discussion
The past decade has seen many countries scale up school-
based deworming programs to improve STH control, in
accordance with current WHO targets that are focused on
achieving 75% worldwide coverage of at-risk school- and
preschool-age children by 2020 [7]. With under a year
remaining to this target, there is vigorous discussion un-
derway regarding STH control targets and recommenda-
tions, including for the WHO 2020–2030 NTD Road
Map. On the basis of evidence from mathematical and
economic modelling studies and meta-analysis, there have
been calls to expand deworming programs for STH con-
trol community-wide [13, 20, 38].
Empirical evidence from field-based research is needed to
confirm the predicted additional benefits of community-
wide deworming. The CoDe-STH trial is one of the first
RCTs comparing the impact of community-wide mass
deworming and school-based targeted deworming on STH
infections, and the first in South East Asia. This trial will
provide robust evidence regarding the differential impact of
school-based and community-wide deworming on STH in-
fections among school-age children, who are at high risk of
STH-associated morbidity. The use of qPCR to diagnose
and quantify infections among the study population will
not only allow for a more accurate determination of disease
prevalence and intensity before and after deworming [30,
39], but will also contribute to the evidence base for using
more sensitive diagnostic techniques to monitor the impact
of deworming. This is an increasingly important consider-
ation as global deworming efforts continue and STH preva-
lence and intensity declines to that undetectable by
microscopy in many regions [37, 40].
Mathematical modelling approaches will be used to
determine the longer-term impact of mass and targeted
deworming beyond the trial follow-up period, and exam-
ine at what true prevalence of infection (determined by
the most sensitive diagnostic method) deworming pro-
grams can cease, with a high probability that transmis-
sion has been interrupted. Furthermore, the CoDe-STH
study will include assessment of the cost-effectiveness of
mass and targeted deworming, and the acceptability and
feasibility of the two approaches within communities,
schools, local program implementers, and policymakers.
Taken together, the findings from these multiple compo-
nents of the CoDe-STH trial will provide a comprehen-
sive picture of evidence to policymakers, donors, and
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other key stakeholders in the NTD sector. This evidence
has the potential to inform future WHO guidelines and
recommendations for STH control programs, in order to
sustain and build on the success of recent deworming
efforts, and maximise benefits to at-risk populations
worldwide.
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